On Oct. 22, the Food and Drug Administration (FDA) approved the first drug for treating COVID-19. Remdesivir, an antiviral medication given intravenously, is now approved for anyone hospitalized with COVID-19. It works by blocking the virus’s ability to make more copies of itself. Earlier this year, the drug had received emergency use authorization (EUA), which falls short of approval but is granted during a public health crisis if there is encouraging data supporting its potential benefits. Approval means the drug’s maker, Gilead, provided more information to the FDA on the medication’s effectiveness and safety than was used to issue the EUA.
“This decision by the FDA is a milestone in the treatment of hospitalized patients with COVID-19,” says Dr. Andre Kalil, professor of internal medicine at University of Nebraska Medical Center who was among the first to treat patients from the Diamond Princess Cruise ship with remdesivir and runs one of the drug’s clinical trials. “Remdesivir shortens the recovery time by 5-7 days, provides 50% faster clinical improvement, prevents patients’ progression to mechanical ventilation, and is associated with a 45% mortality reduction in the first two weeks of disease. These are real and meaningful benefits to our patients.”
The FDA decision is based on three randomized controlled trials that found that people receiving remdesivir shortened their recovery time. While the data did not find a statistically significant benefit in reducing mortality, doctors involved in one of the studies, published in the New England Journal of Medicine (NEJM), reported a trend toward reduced mortality after about a month, especially among people who received the drug early in their infection, as Kalil notes. Patients receiving the drug also needed less additional oxygen and were less likely to progress to severe disease compared to those receiving placebo. The NEJM study was placebo-controlled and supported by the U.S. National Institute of Allergy and Infectious Diseases.
The other two studies, sponsored by Gilead, did not include placebo controls, but compared patients receiving the drug and standard of care to those getting standard of care alone. The drug was effective, and those receiving five days of remdesivir treatment improved as much as those receiving a 10-day course.
The National Institutes of Health now includes remdesivir as part of its recommended treatment strategy for hospitalized COVID-19 patients, and doctors treating patients have said that the drug is one of the reasons that death rates from the disease may have started to drop since the beginning of the pandemic. Other medications and treatment strategies, such as anti-inflammatories and keeping patients on their stomachs to prevent worsening respiratory symptoms, are other likely contributors to the decline in death rates.
The FDA approval comes days after a study from the World Health Organization found no benefit of the drug in reducing early death or in preventing progression to serious disease among nearly 3000 COVID-19 patients. That study, however, did not include a placebo control and compared outcomes to standard of care. It’s also not clear how sick the patients in that study were and therefore how meaningful the results are.
The NEJM study included hints that people who receive the drug earlier in their disease may benefit more, and doctors are already studying whether people with mild symptoms but who don’t need to be hospitalized can be treated with remdesivir on an outpatient basis.
Cyber Attack on Vaccines
Indian drugmaker Dr Reddy’s, which is to run clinical trials of Russia’s Sputnik V Covid-19 vaccine, said it has isolated all its data centres in the wake of a cyber-attack. “We are anticipating all services to be up within 24 hours and we do not foresee any major impact on our operations due to this incident,” the company said in a statement.
Business news channel ET Now, citing sources, said the company has shut all key plants across the globe due to the data breach. The plants in the UK, US, Brazil, India and Russia have been impacted due to the breach.
It is not yet known if the attack was related to Dr Reddy’s work on Covid-19. Beside the trial of the Russian vaccine, the drugmaker also has tie-ups with global firms to sell coronavirus treatments remdesivir and favipiravir in India.
Cyber-attacks to steal proprietary information is not rare. Early in July, security agencies of the United States, United Kingdom and Canada said a Russia-linked hacking group is targeting universities involved in the Covid-19 vaccine research. The same month, the Indian Computer Emergency Response Team (CERT-In), India’s nodal cybersecurity agency, said Indian healthcare services and educational institutions have faced increased cyber-attacks from China and Pakistan since the nationwide lockdown in mid-march.
COVID Vaccination Best for the Older Adults
The Covid-19 vaccine candidate developed by the Oxford University and AstraZeneca has prompted a robust immune response in elderly people, the Financial Times reported, citing people familiar with the findings. The observations are from the so-called immunogenicity blood tests done on a subset of older participants of the trial. Oxford has not officially commented on the report.
A safe and effective vaccine for the elderly is crucial to beat the pandemic as they are among the most at-risk population. But the fact that the immune system weakens with age, raises fears that the very group that most needs the protection may generate the least effective response against a vaccine.
“If what they have is data which shows that the vaccine generates good immunity, as measured in the laboratory, in the overage group — plus 55-year-old — and that also includes good responses in people who are even older than that, I think that’s a promising sign,” Jonathan Ball, professor of virology at the University of Nottingham, said.
Another candidate to have shown promise among the elderly is the mRNA vaccine developed by Moderna, though that too is a preliminary finding. Russia’s Gamaleya Institute has also claimed that its Sputnik V is effective on the elderly but the claim has not been independently reviewed.
The FT report comes shortly after Oxford-AstraZeneca received clearance from the US FDA to restart its trial in the country after pausing it due to potential safety concern — a volunteer in the UK trial had fallen ill.
“The restart of clinical trials across the world is great news as it allows us to continue our efforts to develop this vaccine to help defeat this terrible pandemic,” Pascal Soriot, AstraZeneca’s CEO, said in a statement. The US trial of the vaccine candidate developed by Johnson & Johnson, too, is set to resume after a brief pause.
You can come to India for family or business, but not for pleasure The Ministry of Home Affairs (MHA) on Thursday came out with a notification permitting “all OCI and PIO card holders and all other foreign nationals intending to visit India for any purpose, except on a tourist visa“.
Announcing the “graded relaxation”, the MHA will “restore with immediate effect all existing visas (except electronic visa, Tourist Visa and Medical Visa)” — for visas that may have expired, fresh visas will be issued while for medical visa, foreign nationals need to apply afresh.
The Centre had on March 11 suspended all visas, with relaxation being granted in June for “foreign businessmen coming to India on a Business visa” and those coming for purposes of work.
It may be recalled that hotels were allowed to reopen only in August while tourist sites like the Taj Mahal were reopened last month. Though foreign tourists constitute just 0.5% of all tourists — India received 10.89 million foreign tourists in 2019 — the country earned almost Rs 2.11 lakh crore as forex from them last year.

Dr. Sudhakar Jonnalgadda said this is first time in AAPI history in Association with AHA observe the world restart Heart Day. It’s a total commitment to the joint efforts by AAPI and AHA. “I am very impressed with the energy and strength of the leaders who have taken upon themselves this noble task on creating awareness and educating the physicians and the public on this very serious disease, especially among South Asians in the US. We have the talents, skills, strength and the commitment. Let’s put them to work and help our brethren.”
Dr. Brahma Sharma, a prominent cardiologist, serving as the Chair of the AAPI And AHA Liason Committee on South Asians CVD, said, “For too long, we South Asians have silently suffered from senseless premature death of our loved ones from cardiac arrests in our homes but no more , we have to be proactive so Under this historic AAPI – AHA alliance , we plan to take this initiative of Hands only CPR” to every household so we can feel comfortable to pitch in and rescue these previous lives in first few minutes before help arrives “
During the event, AAPI stressed the importance of Hands Only CPR for bystanders and immediately rescue lives and reduce “Out of Hospital Cardiac Arrests. A Hands on only CPR demonstration was led by Dr. Anupama Gotimukula, President-Elect of AAPI. “Every family member needs to know how to do “Hands Only CPR” to save a life from sudden Cardiac Arrest!” It’s a day to commemorate the importance of Anesthesia specialty in the medical field with which we are able to make wonders in the medical field, especially the surgical specialties and able to do all complex surgeries successfully today!!
Dr. Jonnalagadda was born in a family of Physicians. His dad was a Professor at a Medical College in India and his mother was a Teacher. He and his siblings aspired to be physicians and dedicate their lives for the greater good of humanity. “I am committed to serving the community and help the needy. That gives me the greatest satisfaction in life,” he said modesty. Ambitious and wanting to achieve greater things in life, Dr. Jonnalagadda has numerous achievements in life. He currently serves as the President of the Medical Staff at the Hospital. And now, “being elected as the President of AAPI is greatest achievement of my life,” As the President of AAPI, the dynamic physician from the state of Andhra Pradesh, wants to “develop a committee to work with children of AAPI members who are interested in medical school, to educate on choosing a school and gaining acceptance; Develop a committee to work with medical residents who are potential AAPI members, to educate on contract negotiation, patient communication, and practice management; Develop a committee to work with AAPI medical students, and to provide proctorship to improve their selection of medical residencies.” Dr. Jonnalagadda wants to emphasize the importance of Legislative Agenda both here in the US and overseas, benefitting the physicians and the people AAPI is committed to serve. According to him, “The growing clout of the physicians of Indian origin in the United States is seen everywhere as several physicians of Indian origin hold critical positions in the healthcare, academic, research and administration across the nation.” He is actively involved with the Indian community and member at large of the Asian Indian Alliance, which actively participates in a bipartisan way to support and fund electoral candidates. His vision for AAPI is to increase the awareness of APPI globally and help its voice heard in the corridors of power. “I would like to see us lobby the US Congress and create an AAPI PAC and advocate for an increase in the number of available Residency Positions and Green Cards to Indian American Physicians so as to help alleviate the shortage of Doctors in the US.” . A Board-Certified Gastroenterologist/Transplant Hepatologist, working in Douglas, GA, Dr. Jonnalagadda is a former Assistant Professor at the Medical College of Georgia. He was the President of Coffee Regional Medical Staff 2018, and had served as the Director of Medical Association of Georgia Board from 2016 onwards. He had served as the President of Georgia Association of Physicians of Indian Heritage 2007-2008, and was the past Chair of Board of Trustees, GAPI. He was the Chairman of the Medical Association of Georgia, IMG Section, and was a Graduate, Georgia Physicians Leadership Academy (advocacy training). “AAPI and the Charitable Foundation has several programs in India. Under my leadership, we will be able to initiate several more program benefitting our motherland, India,” Dr. Jonnalagadda said. The solemn Award Ceremony by IAPC was led by Padma Shri Dr. Sudhir Parikh, Chairman of Parikh Media and an active leader of AAPI. The virtual ceremony was organized, among others, by Dr. Joseph Chalil, IAPC Chairman; Korason Varghese, Award Committee Chair; & Dr. P.V. Baiju, IAPC Board Member. Dr. Vinod K. Shah, Managing Director of MedStar Shah Medical Group, CEO of Health Prime, and former President of AAPI, was conferred with the prestigious Karma Shrestha Award. WHEELS Global Foundation, a charitable initiative by the Indian Institute of Technology alumni, was conferred The Sathkarma Award. Ranjani Saigal, Executive Director of Ekal Vidyalaya, and Dean Nitin Nohria, Dean of Harvard Business School, were given The SathKarma Award. Ambassador Pradeep Kapur, the author of the book Beyond Covid-19 Pandemic and former Ambassador of India to Chile and Cambodia, received the Excellence in Literature Award. Chancellor of the University of California San Diego, Pradeep Khosla, was awarded the Excellence in Technology & Education Award. The Humanitarian Award was given to Dr. Sunil D. Kumar, Broward Health Medical Center, and former President of AKMG. Satish Korpe, the past President of the Indian American Forum for Political Education, and Madhavan B. Nair, former President of FOKANA, received the Community Service Award. Lalit K. Jha, Chief US Correspondent for Press Trust of India (PTI), was given the IAPC Media Excellence Award. The Indo-American Press Club (IAPC), a 501 (c) 3 Non-Profit Organization headquartered in New York, was formed in 2013 with the ideals of providing a common platform to journalists of Indian-origin living in the United States and Canada committed to professionalism and well-being of the larger society. IAPC is also committed to recognize and honor the outstanding entities and individuals in the community that creates a social impact and excel in their field of profession, culture, service, and business.
A true visionary and reputed for his excellence in healthcare, education, leadership and social services, Dr. Shah received his medical degree from Bombay University, completed his cardiology training at Georgetown University Hospital. Dr. Shah moved to rural Southern Maryland 45 years ago with his wife, Dr. Ila Shah, a Pediatrician and his brother, Dr. U.K. Shah, a Gastroenterologist, and together they founded Shah Associates, the largest private multi-specialty practice in Maryland.
Dr. Shah has consistently used his personal connections with US Lawmakers to advocate for an increase in the number of medical schools and residencies, with the dual goal of improving access to care nationwide and allowing more qualified and deserving graduates, such as those from India, to practice in the US. As the President of AAPI, Dr. Shah facilitated trips to India with both Maryland Governor Martin O’Malley and a number of Members of Congress, including the current House Majority Leader, Steny Hoyer. In addition to general cultural exchange, Dr. Shah helped bring about the creation of a sister state relationship between Maryland and Maharashtra, with the purpose of encouraging research and investment in life-saving medical technology.
His literary skills came to be recognized around the world, when he penned the publication of “Antarnaad – Introspection,” created with images of India’s past, present and future with the purpose of educating younger generations in both India and the US as well as US lawmakers as to the strength of democracy. The accompanying documentary film he had produced describes the compelling story of The Golden Era, Islamic Invasion and British India, and was followed by Freedom Movement, Partition, and the Post-Independence India with emphasis on human weakness, corruption, license Raj, and the revolt by the people leading to the Promised Land.
Ambassador Pradeep Kapur is an acknowledged “luminary diplomat,” with a distinguished career working with leaders and policymakers in different continents of the world: Asia, Africa, Europe, North America, and South America. Author and editor of many books, he was Ambassador of India to Chile and to Cambodia, and Secretary at the Indian Ministry of External Affairs, before joining as an academic in reputed universities in USA and India. A graduate of the globally acclaimed Indian Institute of Technology, Delhi (IIT-D), he is Executive Director of Smart Village Development Fund (SVDF); International Economic Strategic Advisor, Intellect Design Arena; and Chairman, Advisory Council, DiplomacyIndia.com. His contributions in healthcare include setting up of BP Koirala Institute of Health Sciences in Eastern Nepal which is acclaimed as an exemplary bilateral India Nepal initiative.
Dr. Joseph Chalil, an author of several scientific and research papers in international publications, is the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida and a member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council. A veteran of the U.S. Navy Medical Corps, he is board certified in healthcare management. He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Dr. Chalil is the Chairman of the Indo American Press Club (IAPC), the largest ethnic fraternity of Indian American and Indian Canadian media with a mandate to help shape a world through media that is fair, just, and equitable for all, and future generations. He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care. With years of experience working in the U.S. healthcare system, he discusses the challenges of healthcare delivery, including providing quality, affordable patient care to all, and alternate templates for health insurance.
Dr. Brahma Sharma, a prominent cardiologist affiliated with VA University of Pittsburgh, and serving as the Chair of AAPI-AHA Liaison committee on South Asian Heart Disease, said, “This is a historic day for south Asian community and we all appreciate the bipartisan efforts by Rep. Pramila Jaypal and Rep Joe Wilson (R- SC). It is gratifying to see this hidden threat for South Asians community finally being recognized. We have to continue this advocacy, so it passes through US Senate as well and provides the necessary support for education, research for early detection , prevention and even reversal of this epidemic of cardio-metabolic disease among South Asians who are at the highest risk.”
Dr. Sudhakar Jonnalgadda offered total commitment to these efforts. “I am very impressed with the energy and strength of the leaders who have taken upon themselves this noble task on creating awareness and educating the physicians and the public on this very serious disease among South Asians in the US. We have the talents, skills, strength and the commitment. Let’s put them to work and help our brethren.” For more information on AAPI, please visit:
“I applaud AAPI for being a dynamic body, spearheading legislative agendas and influencing the advancement of medical care not only in the US but across the globe,” Shri Naidu said. “I am also glad to know that AAPI’s mission for India is to play an important role in making quality healthcare accessible and affordable to all people of India. It is indeed a laudable objective as both accessibility and affordability are the need of the hour, especially in a vast developing country like India with a huge population of middle class and lower middle class,” Shri Naidu said.
A dedicated pool of Physicians led by Dr. Meher Medavaram, Convention, Cahir, has been working hard to make the convention a memorable experience for all. “With Corona Virus impacting every aspect of life around the world, posing several challenges in carrying out with numerous plans and programs for AAPI in 2020, Dr. Suresh Reddy, the 36th President of AAPI, has been right on task and has devoted the past one year leading AAPI to stability and greater heights. The deadly pandemic, COVID-19 that has been instrumental in the lockdown of almost all major programs and activities around the world, could not lockdown the creative minds of AAPI leaders,” she said. 
A Coffee Table Book, chronicling the history of AAPI was released. “This coffee table book is dedicated to all the “First Ladies” who have sacrificed innumerable hours of their family time for the sake of AAPI,” Dr. Suresh Reddy said. “My sincere gratitude and appreciation to all of the leaders of AAPI, and in particular to Dr. Ranga Reddy for being the “Shrusti-Kartha” of this book. He chronicled the history of AAPI. Spending thousands of hours in the past 25 years, making sure this book saw the light of the day. He wrote the biographic sketches of each past President with inputs from most of them.”
Describing Indian American Physicians as the “Best of America,” Raja Krishnamoorthi praised them for their dedication and skills. “We are proud of your achievements,” he told AAPI members. Given that a physician of Indian origin sees every 7th patient in this country and every 5th patient in rural and inner cities across the nation, the reach and influence of AAPI members’ contributions go well beyond the Convention, he said, while urging everyone to participate actively during the General Election on November 3rd.
Ambassador Amit Kumar acknowledged with gratitude the contributions of Indian American Physicians, especially during the pandemic. He referred to AAPI members writing over 1,000 prescriptions to the stranded visitors and students from India during the Covid pandemic. Ambassador Kumar thanked AAPI for its numerous initiatives to benefit people in India thorugh AAPI’s collaborative efforts with Apollo Hospital and Tata Trust in India.
The session on Surgical Management of Intracerebral Hemorrhage was led by Dr. Joseph C. Serrone, Assistant Professor, Neurosurgery and Radiology at Loyola University Medical Center & Neurosurgeon, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois; and, Dr. Suresh Reddy, Associate Professor of Radiology at Loyola University Medical Center & Chief of Radiology, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois.
“The convention offered a variety of ways to reach physicians and their families. It provided access to AAPI members who attended in person and virtually, regarding new products and services,” Dr. Satish Kathula, Treasurer of AAPI, said.

Ambassador Taranjit Singh Sandhu greeted AAPI and FAPI members as “we are commemorating the 74th year of India’s Independence.” Pointing to how the pandemic has changed our lives, he said, “Covid has taken a toll on human lives. I congratulate AAPI and FAPI for organizing this special Medical Symposium.”
Dr. Sudhakar Jonnalagadda, President of AAPI, said, “This year India celebrates its 74th Independence Day remembering the sacrifices made by the freedom fighters, political leaders and citizens in order to free the motherland from colonial rule. This year, COVID-19 has eliminated the ability for spectators and celebrations. The virtual world allows celebrations to proceed in a different manner, but this is also an opportunity to be re-inspired by the legacy of the Father of Nation. After all, isn’t service of mankind the best way to celebrate India’s Independence?”
The report details the actions of 58 non-profit organizations re-purposing their efforts in response to the pandemic and illustrates the power of the Indian Diaspora community. “Never before have we witnessed such a united all-out community relief effort amongst the diaspora. One of the most unique aspects we witnessed was the efforts by the next generation of philanthropists through their incredible volunteer efforts,” said Gabrielle Trippe, Indiaspora Philanthropy Initiatives Manager.
The vaccine uses a harmless-to-humans chimpanzee adenovirus as a delivery vector. That virus is modified to carry spike proteins from SARS-CoV-2—the component of the coronavirus that, in theory, should induce the sought-after immune response in humans. What the researchers were looking for were two kinds of immune reaction: humoral immunity, or the system-wide generation of antibodies against the virus; and cellular immunity, or the activation of immune system T-cells that attack human cells infected with the COVID-19 virus. Oxford vaccine triggers immune response, trial findsA Covid-19 vaccine candidate developed by the Oxford University has safely prompted a protective immune response in hundreds of volunteers who got the shot in an early trial, preliminary findings published Monday in the journal Lancet said. The vaccine, ChAdOx1 nCoV-19 (also called AZD1222), designed by Oxford and developed by AstraZeneca, the Anglo-Swedish pharma major, triggered a dual immune response in people aged 18 to 55 that lasted at least two months. The preliminary
Dr. Jonnalagadda, who will be administered the oath of office as the President of AAPI at the 1st ever Virtual Oath ceremony on July 11th, 2020, has vowed to take the nearly four decades old organization to the next level and “bring all the AAPI Chapters, Regions, Members of the Executive Committee and Board of Trustees to work cohesively and unitedly for the success of AAPI and the realization of its noble mission.” He wants to increase AAPI membership by offering more benefits and opportunities for members.
As a very compassionate, goal oriented and with strong leadership skills, Dr. Jonnalagadda will be assisted by an executive committee consisting of Dr. Anupama Gotimukula, President-Elect; Dr. Ravi Kolli, Vice President, Dr. Amit Chakrabarty, Secretary of AAPI; Dr. Satish Kathula, Treasurer of AAPI, and Sajani Shah, Chair of AAPI’s BOT.
He was born in a family of Physicians. Dr. Jonnalagadda’s dad was a Professor at a Medical College in India and his mother was a Teacher. He and his siblings aspired to be physicians and dedicate their lives for the greater good of humanity. “I am committed to serving the community and help the needy. That gives me the greatest satisfaction in life,” he says with modesty.
In order for us to help and support the youngsters who want to pursue Medicine and want to succeed in their dreams to be successful healthcare professionals, “I envisage a plan for young aspiring physicians of Indian origin,” he had told them. “I want to launch a program that will, Educate the Residents from India on ways to negotiate contract with insurance companies and Medical Institutions; Identify Centers/Areas across the US for Clinical Observership Program for aspiring young physicians; and, help Youth who want to pursue medicine as their career, guide them with the skills for participating in interviews and ways to succeed in school. This is the first time ever AAPI is embarking on this new initiative and I am excited to be able to take this to the next level”
Dr. Jonnalagadda was the Chair, AAPI Awards Committee in 2015, and had served as the Alumni Chair, Atlanta AAPI Convention in 2006. His leadership and commitment were much appreciated when he had served as the Convener of AAPI 2012 Fundraiser, and helped AAPI raise $150,000, and in the 2013 Fundraiser, he had helped AAPI raise $120,000 in Atlanta. In 2016, he had helped in AAPI 2016 Fundraiser through his efforts in Atlanta raise funds for Hurricane Harvey.
The highlight of the ceremony was Dr. Joseph M. Chalil assuming charge as the Chairman, while Dr. SS Lal became the President of Indo American Press Club. Also, along with the two dynamic leaders, several new members of the Board of Directors, Executive Committee members, and Local Chapter leadership were administered the oath of office. In his acceptance speech, Dr. Chalil said, “Your choice humbles me, and I promise to do my duties with the best of my abilities.” Describing current phase in human history as “unprecedented times for the journalists and the media,” he pointed out that “AT LEAST 146 JOURNALISTS HAVE DIED FROM CORONAVIRUS IN 31 COUNTRIES.” The new Executive Committee led by Dr. S S Lal, Annie Koshy, C G Daniel, James Kureekattil, Prakash Joseph, Sunil Manjanikara, Biju Chacko, Andrews Jacob, Raj Dingra, Annie Chandran, Neethu Thomas, Innocent Ulahannan, Baiju Pakalomattom, O. K. Thyagarajan, Shiby Roy and Korasan Varghese were administered the oath of office by Chairman Dr. Joseph M Chalil.
In his Presidential Address, Dr. Lal highlighted the importance of journalists and the need to coordinate and bring together journalists under one umbrella. “And it is the commitment and sacrifice of the leaders and members of this organization that has helped us build collaborations between the journalists and writers of the US and India,” Dr. Lal said. Ambassador Pradeep Kapur, in his keynote address stressed the importance of the media, especially in these challenging times as they work hard to bring the truth before the public. Dr. Shashi Tharoor, a Member of Indian Parliament, in his message stressed the importance of media and congratulated IAPC for its contributions to the society. Isaac John Pattaniparambil from Khaleej Times in Dubai, MG Radhakrishnan from Asianet NewsTV, Srikantan Nair from 24News, Preetu Nair from Times of India were others who addressed the IAPC members and felicitated the organization for its growth and success in a short period of seven years,
BOB MIGLANI: Bestselling Author, Speaker and Founder of Embrace the Chaos – a change & transformation company. His Washington Post Bestselling book titled, Embrace the Chaos:How India Taught Me to Stop Overthinking and Start Living – celebrated the India experience of dealing with uncertainty and learning to embrace change in our daily lives and to always be moving forward. Bob’s other books include Treat Your Customers, about business lessons he learned working at his family’s Dairy Queen store and Make Your Own Luck, which he launched in India in November 2019. Today, Bob speaks, writes and advises companies on change and transformation. He lives in New Jersey, USA.
BADAL SHAH: Badal Shah is another recent exemplar of an Indian coming from humble background from India and fulfilling his American dream. A 22 year old pharmacist who came to US in 2012, in search of his dream, rose through the ranks to become the youngest Managing Director of QPharma Inc.- a premium Medical, Commercial and Compliance partner of Pharmaceutical companies and was recently declared as one of the top 100 healthcare leaders in 2020 by IFAH (International Forum on Advancement in Healthcare). He pioneered the unique approach of “How to achieve effective medical communication and optimize field force during drug launch” which helped in successfully launching more than 25 drugs that were paramount in treating various diseases. He created the entire Health analytics services in last three years at QPharma and created unique platforms and solutions, which are being used by more than 2500 pharmaceutical leaders from top 20 pharmaceutical companies all over the world. 







